BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

AnaptysBio, Inc. 

10835 Road to the Cure
Suite 100
San Diego  California  92121  U.S.A.
Phone: 858-362-6295 Fax: 858-362-6296


SEARCH JOBS




Industry
Biotechnology

Segment
Biotechnology





 Company News
AnaptysBio, Inc. Announces Issuance Of United States Patent Covering Proprietary Antibody Humanization Technology 4/3/2014 9:32:54 AM    More...
Tesaro, Inc. (TSRO), AnaptysBio, Inc. Strike Immuno-Oncology Pact Worth $125 Million 3/13/2014 7:02:32 AM    More...
AnaptysBio, Inc. Announces Development Of Novel Anti-IL33 Therapeutic Antibody 1/10/2014 10:37:15 AM    More...
AnaptysBio, Inc. Announces Antibody Development Agreement With Momenta Pharmaceuticals, Inc. (MNTA) 12/17/2013 10:44:30 AM    More...
AnaptysBio, Inc. Receives Allowance of US Patent Covering Proprietary ABELmAb™ Libraries 10/17/2013 9:54:32 AM    More...
AnaptysBio, Inc. Awarded U.S. Government Contract to Develop Anti-Ricin Antibodies 5/17/2013 8:52:05 AM    More...
AnaptysBio, Inc. Develops Novel Antibody Scaffold With Extreme Thermostability 12/4/2012 9:42:31 AM    More...
AnaptysBio, Inc. Expands Patent Portfolio with Issuance of U.S. Patent to in Vitro Somatic Hypermutation 10/18/2012 10:49:52 AM    More...
AnaptysBio, Inc. Expands Leadership Team With Addition of Dr. Andrew J. Mcknight 8/8/2012 10:34:46 AM    More...
AnaptysBio, Inc. Announces Antibody Discovery Partnership With Gilead Sciences, Inc. (GILD) 5/1/2012 11:53:28 AM    More...
1234